Influenza-like Illness Incidence Is Not Reduced by Influenza Vaccination Influenza vaccination reduces the number of influenza virus infections but not the overall number of illness.
State of infectious diseases in the Netherlands 2016 The most notable infectious disease outbreak in 2016 was the large Zika virus outbreak in Latin America.
Annual report 2016 now online In our annual report, we look back at compelling RIVM projects and research in which RIVM was involved in 2016. Our expertise is broader than what we can showcase in this report.
Risks of potential release of genetically modified mosquitoes evaluated On Saba, a Dutch Caribbean island, diseases such as dengue, chikungunya and zika can be reduced by the use of genetically modified mosquitoes.
Resistant bacteria in wastewater Our wastewater contains bacteria that are resistant to antibiotics. Residues of antibiotics are also found in wastewater.
Trend scenario PHF- 2018 identifies societal challenges for the future If historical trends continue unchanged, dementia will be the leading cause of disease burden in 2040 and the main cause of death.
Antimicrobial resistance is stable, but alertness remains necessary The number of bacteria strains resistant to antibiotics in humans has remained stable in the Netherlands over the past year.
Mental care still the most expensive of all In 2011, 19.6 billion euros was spent on the treatment of mental disorders. This amounted to 22% of the total expenditure on health and welfare during that year.
Risks of eHealth technology RIVM and Nictiz have made an overview of the risks that eHealth applications may entail and how these risks can be controlled.
Key organisations unite to improve benefit and risk assessments of vaccines Leading organisations have joined forces to launch a unique project that will pave the way for a pan-European framework for rapidly assessing and communicating the benefits and risks of vaccines.